How did HCA's Q1 2024 EPS outperform forecasts?

HCA's Q1 2024 EPS outperformed forecasts due to several key factors:

1. **Revenue Growth**: HCA reported a revenue total of $18.285 billion for Q1 2024, surpassing analyst estimates of $18.234 billion. This revenue growth, driven by increased admissions, contributed to the higher EPS.
2. **Strategic Initiatives**: The company's strategic initiatives, including network development and technology integration, have contributed to a 9% increase in adjusted EBITDA. These initiatives have likely led to improved profitability and a better EPS.
3. **Cost Management**: HCA's focus on cost management and operational enhancements may have led to better financial performance and a higher EPS. The company's investment in AI and operational improvements suggests a proactive approach to managing costs and improving efficiency.

In summary, HCA's Q1 2024 EPS outperformance can be attributed to strong revenue growth, strategic initiatives, and effective cost management. These factors combined to enable HCA to exceed EPS forecasts, reflecting the company's solid financial performance and growth prospects.